Welcome : Guest

Protalix BioTherapeutics, Inc. (Israel) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Protalix BioTherapeutics, Inc., which is principally involved in the Manufacture and Distribution of Biopharmaceuticals. Illustrated with 31 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-40487
Price: $1550
Company Type: Public
Pages: 35
Date: October 2015
Market Data Tables: 31

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Protalix BioTherapeutics, Inc.’s Revenues by Category Worldwide (2013) in Percentage for Deferred Revenues from the License and Supply Agreement with Pfizer, Milestone Payment and Revenues from Selling Products......3
Biopharmaceuticals......5
Table 2: Biopharmaceuticals Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......5
Table 3: Pharmaceutical Drugs Market by Category in Germany (2014) – Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......6
Table 4: Proteins Market by Segment in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibody (MAb), Nerve Growth Factor (NGF), and Somatropin......7
Table 5: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......8
Table 6: Drugs Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......9
Biologics......10
Table 7: Biological Drugs Market by Product Segment Worldwide (2015)-Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......10
Table 8: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......11
Table 9: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......12
Table 10: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......13
Table 11: Injectibles Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Standard Injectibles, Vaccines and Others......14
Table 12: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......15
Table 13: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......16
Table 14: Rheumatology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......17
Table 15: Rheumatology Drugs Market by Product Type in the US (2014) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......18
Table 16: Orthopedics Market by Category Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Biologics, CMF, Dental Implants, Extremities, Hips, Knees, Spine, Sports Medicine, and Trauma......19
Biosimilars......20
Table 17: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......20
Branded Stimulant Drugs......21
Table 18: Branded Stimulant Drugs Market by Prescription Worldwide (2015)-Percentage Share Breakdown by Value for Adderall XR, Focalin XR, Vyvanse and Others......21
GLP-1 based Drugs......22
Table 19: GLP-1 Sales by Category in the US (2014) - Percentage Market Share Breakdown by Value for Byetta/Bydureon (AZN), Lixisenatide (SNY), and Victoza (NovoNordisk)......22
Biopharmaceuticals......23
Table 20: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......23
Table 21: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co, Ltd., Kyowa Hakko Kirin Co, Ltd., North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co, Ltd., and Others......24
Bio Contract Manufacturing Organization (CMO)......25
Table 22: Market Shares of Leading Bio- Contract Manufacturing Organization (CMO) Operations Worldwide (2015) - Percentage Breakdown by Volume for C.H. Boehringer Sohn AG & Co. KG, Celltrion, Lonza Group, Samsung Biologics, and Others......25
Biosimilars......26
Table 23: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015)-Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......26
GLP-1 based Drugs......27
Table 24: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......27
Insulin......28
Table 25: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......28
Nerve Growth Factor (NGF)......29
Table 26: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co, Ltd., Staidson (Beijing) Biopharmaceuticals Co, Ltd., Xiamen Bioway Pku Co, Ltd., and Others......29
Gaucher Disease......30
Table 27: Market Shares of Leading Drugs for Gaucher Disease in Brazil (2015)-Percentage Share Breakdown by Value for Cerezyme, Eliglustat and Others......30
Table 28: Market Shares of Leading Drugs for Gaucher Disease Worldwide (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......31
Table 29: Market Shares of Leading Drugs for Gaucher Disease in EU (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......32
Table 30: Market Shares of Leading Drugs for Gaucher Disease in the US (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......33
Table 31: Market Shares of Drugs for Gaucher Disease by Region Worldwide (2014) - Percentage Breakdown by Value for European Union, United States and Rest of World......34